ライフサイエンスコーパス: safety of

1 We aimed to assess the activity and safety of dabrafenib plus trametinib treatment in previously

2 the pharmacokinetic and pharmacodynamic characteristics and safety of fitusiran.

3 investigate available evidence regarding effectiveness and safety of surgical versus conservative treatment of acute app

4 This study aimed to examine the effectiveness and safety of TMVR in a cohort of patients with native valve MR w

5 The efficacy and safety of 0.005% calcipotriol ointment combined with 5% 5-FU

6 To compare the efficacy and safety of 2 sclerosants used to treat reticular veins: 0.2% p

7 Evidence exists for the efficacy and safety of 6-month isoniazid monotherapy, rifampicin monothera

8 Purpose To evaluate the efficacy and safety of a clofarabine-based combination (CLARA) versus conv

9 zed, placebo-controlled trial, we assessed the efficacy and safety of adalimumab in children and adolescents 2 years of a

10 objective of this study was to investigate the efficacy and safety of adjunctive lanicemine (NMDA channel blocker) in the

11 the aim of this study to evaluate feasibility, efficacy and safety of ADVOS in the first 14 patients ever treated with th

12 We aimed to assess the efficacy and safety of ceftazidime-avibactam in patients with nosocomial p

13 We assessed the efficacy and safety of ceritinib versus platinum-based chemotherapy in the

14 We aimed to analyse the efficacy and safety of clemastine fumarate as a treatment for patients wit

15 The efficacy and safety of fixed-dose combination of AM and PQP was comparable

16 We aimed to test the efficacy and safety of graded exercise delivered as guided self-help.

17 We sought to evaluate the efficacy and safety of grass pollen intradermal immunotherapy in the treat

18 We aimed to assess the efficacy and safety of idelalisib in combination with a second-generation

19 Conclusion The durable clinical efficacy and safety of MR imaging-guided HIFU were demonstrated.

20 domized, double-blind trial designed to assess efficacy and safety of nintedanib plus chemotherapy as first-line treatmen

21 sessment and modelling are required to monitor efficacy and safety of ongoing strategic vitamin D fortification.

22 We aimed to assess the efficacy and safety of pacritinib versus best available therapy in patient

23 This phase 2 study was designed to test the efficacy and safety of pembrolizumab, a humanized PD-1-blocking antibody,

24 To evaluate the long-term (24-month) efficacy and safety of ranibizumab 0.5 mg administered pro re nata (PRN) w

25 To evaluate the efficacy and safety of ranibizumab 0.5 mg treat-and-extend (T&E) versus mo

26 We assessed the efficacy and safety of re-treating malaria patients with uncomplicated fai

27 We aimed to assess the efficacy and safety of regorafenib in patients with HCC who have progresse

28 t studies strengthen the evidence base for the efficacy and safety of sublingual immunotherapy in patients with HDM-induc

29 We investigated the efficacy and safety of switching to a single-tablet regimen of darunavir,

30 This trial evaluated the efficacy and safety of tezepelumab (AMG 157/MEDI9929), a human monoclonal

31 clusion, this trial demonstrated production feasibility and safety of infusing high doses of ex vivo-expanded NK cells af

32 We assessed the persistence and safety of MtbDeltasigH, delivered directly to the lungs, in t

33 the use of bone turnover markers for assessment of the bone safety of new medications.

34 To evaluate the cardiovascular and cerebrovascular safety of ranibizumab, 0.5 mg and 0.3 mg, compared with sham

35 The primary objective of this trial was to evaluate safety of IVT or an estradiol vaginal ring in patients with e

36 Improved safety of left ventricular assist devices means that these ar

37 Thermal treatment preserves the microbiological safety of milk, but also induces Maillard reactions modifying

38 CLINICAL RELEVANCE: Relative safety of ranibizumab and bevacizumab is important in choosin

39 These findings support the short-term renal safety of TDF/FTC PrEP in HIV-seronegative young men and sugg

40 To evaluate the efficacy and ocular and systemic safety of netarsudil 0.02% ophthalmic solution, a rho-kinase

41 her follow-up studies are needed to establish the long-term safety of these strategies.

42 Although the safety of these electronic devices is still not fully known,

43 d attention in the last years and is relevant to assess the safety of our consumer products and the emission of potential

44 Primary objectives were to assess the safety of rovalpituzumab tesirine, including the maximum tole

45 These findings challenge the safety of pure nicotine inhalation, i.e., E-cigarettes.

46 To evaluate the safety of concurrent Boston type I keratoprosthesis (KPro) an

47 To determine whether genotype-guided dosing improves the safety of warfarin initiation.

48 are contact for most children, we sought to investigate the safety of care provided to children in this setting.

49 In this study, we investigated the safety of three different sizes of SiNPs (50, 100, and 150 nm

50 ure to provide evidence-based recommendations regarding the safety of procedural interventions performed either concurren